Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,177,815 papers from all fields of science
Search
Sign In
Create Free Account
Fazaclo
Known as:
CLOZAPINE (FAZACLO)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Adrenergic alpha-Antagonists [MoA]
Antipsychotic Agents
Bipolar Disorder
Clozapine 25 MG Disintegrating Oral Tablet [Fazaclo]
Expand
Broader (1)
Clozapine
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Med Check: Sertraline; Nicotine Mouth Spray; FazaClo
T. D'arrigo
Psychiatric News
2019
Corpus ID: 208460923
2012
2012
FazaClo (clozapine) orally disintegrating tablets label
2012
Corpus ID: 20426481
BECAUSE OF A SIGNIFICANT RISK OF AGRANULOCYTOSIS, A POTENTIALLY LIFE-THREATENING ADVERSE EVENT, CLOZAPINE SHOULD BE RESERVED FOR…
Expand
2012
2012
Obsessive-compulsive symptoms in patients with schizophrenia: a naturalistic cross-sectional study comparing treatment with clozapine, olanzapine, risperidone, and no antipsychotics in 543 patients.
Albertine A Scheltema Beduin
,
M. Swets
,
M. Machielsen
,
N. Korver
Journal of Clinical Psychiatry
2012
Corpus ID: 22306242
OBJECTIVE To compare the prevalence of obsessive-compulsive symptoms (OCS) in a population of patients with schizophrenia taking…
Expand
2008
2008
Bioequivalence of Clozapine Orally Disintegrating 100-mg Tablets Compared with Clozapine Solid Oral 100-mg Tablets after Multiple Doses in Patients with Schizophrenia
G. Golden
,
G. Honigfeld
Clinical drug investigation
2008
Corpus ID: 23825198
AbstractBackground: This study compared the bioequivalence of FazaClo® (clozapine orally disintegrating tablets) 100 mg to…
Expand
Review
2007
Review
2007
Behavioral therapy for weight loss in patients with schizophrenia.
R. Ganguli
Journal of Clinical Psychiatry
2007
Corpus ID: 24009514
Compared with the general population, individuals with schizophrenia demonstrate an increased prevalence of obesity. While most…
Expand
2007
2007
Effects of integrated treatment on antipsychotic medication adherence in a randomized trial in recent-onset schizophrenia.
G. Morken
,
R. Gråwe
,
J. Widen
Journal of Clinical Psychiatry
2007
Corpus ID: 18400745
OBJECTIVE Interventions improving adherence to antipsychotic medication are needed. The present study examined the effects on…
Expand
Highly Cited
2006
Highly Cited
2006
Weight management program for treatment-emergent weight gain in olanzapine-treated patients with schizophrenia or schizoaffective disorder: A 12-week randomized controlled clinical trial.
J. Kwon
,
Jung-Seok Choi
,
+5 authors
Chang Geun Oh
Journal of Clinical Psychiatry
2006
Corpus ID: 17110721
BACKGROUND The main objective was to assess the efficacy of a weight management program designed for outpatients taking…
Expand
Review
2005
Review
2005
Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.
F. Cournos
,
K. Mckinnon
,
G. Sullivan
Journal of Clinical Psychiatry
2005
Corpus ID: 34204087
Patients with schizophrenia are at significantly increased risk for infection with human immunodeficiency virus (HIV), hepatitis…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE